| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An intronic deletion in TP53 gene causes exon 6 skipping in breast cancer
|
Voglino, G.
|
|
1997
|
33 |
9 |
p. 1479-1483
5 p.
|
artikel
|
| 2 |
A retrospective cost-effectiveness analysis of interferon as adjuvant therapy in high-risk resected cutaneous melanoma
|
Messori, A.
|
|
1997
|
33 |
9 |
p. 1373-1379
7 p.
|
artikel
|
| 3 |
Artifactual hypoglycaemia during treatment with filgrastim (rHu-met-G-CSF)
|
Illarramendi, J.J.
|
|
1997
|
33 |
9 |
p. 1520-
1 p.
|
artikel
|
| 4 |
Calendar of forthcoming meetings
|
|
|
1997
|
33 |
9 |
p. I-IV
nvt p.
|
artikel
|
| 5 |
Carcinoma of the stomach following the Chernobyl nuclear accident
|
Shchepotin, I.B.
|
|
1997
|
33 |
9 |
p. 1413-1418
6 p.
|
artikel
|
| 6 |
Cochrane cancer clan gathers in Brussels
|
Williams, C.
|
|
1997
|
33 |
9 |
p. 1371-1372
2 p.
|
artikel
|
| 7 |
Commentary
|
Berthold, F.
|
|
1997
|
33 |
9 |
p. 1437-1438
2 p.
|
artikel
|
| 8 |
Cytosolic phospholipase A2, cyclo-oxygenases and arachidonate in human stomach tumours
|
Soydan, A.S.
|
|
1997
|
33 |
9 |
p. 1508-1512
5 p.
|
artikel
|
| 9 |
Differential binding of nuclear proteins to the TP53 gene promoter in male breast tumour
|
Nayak, B.K.
|
|
1997
|
33 |
9 |
p. 1484-1487
4 p.
|
artikel
|
| 10 |
Differential responses to chemoimmunotherapy in patients with metastatic malignant melanoma
|
Mainwaring, P.N.
|
|
1997
|
33 |
9 |
p. 1388-1392
5 p.
|
artikel
|
| 11 |
Duration of colorectal cancer symptoms and survival: the effect of confounding clinical and pathological variables
|
Mulcahy, H.E.
|
|
1997
|
33 |
9 |
p. 1461-1467
7 p.
|
artikel
|
| 12 |
Economic analyses of benefit from interferon-alpha 2B in high-risk melanoma: Trade-offs between completeness, simplicity and clarity
|
Hillner, B.E.
|
|
1997
|
33 |
9 |
p. 1345-1346
2 p.
|
artikel
|
| 13 |
Game-theory models of interactions between tumour cells
|
Tomlinson, I.P.M.
|
|
1997
|
33 |
9 |
p. 1495-1500
6 p.
|
artikel
|
| 14 |
5-HT3 receptor antagonists: Differences and similarities
|
Roila, F.
|
|
1997
|
33 |
9 |
p. 1364-1370
7 p.
|
artikel
|
| 15 |
Immunoneutralisation of gonadotrophin releasing hormone: a potential treatment for oestrogen-dependent breast cancer
|
Ferro, V.A.
|
|
1997
|
33 |
9 |
p. 1468-1478
11 p.
|
artikel
|
| 16 |
International cancer news
|
|
|
1997
|
33 |
9 |
p. 1339-1344
6 p.
|
artikel
|
| 17 |
Interval cancers and cancers in non-attenders in the östergötland mammographic screening programme. Duration between screening and diagnosis, S-phase fraction and distant recurrence
|
Vitak, B.
|
|
1997
|
33 |
9 |
p. 1453-1460
8 p.
|
artikel
|
| 18 |
MDR1 RNA transcripts do not indicate long-term prognosis in colorectal carcinomas
|
Zöchbauer, S.
|
|
1997
|
33 |
9 |
p. 1516-1518
3 p.
|
artikel
|
| 19 |
Messenger ribonucleic acid expression of LH/hCG receptor gene in human ovarian carcinomas
|
Mandai, M.
|
|
1997
|
33 |
9 |
p. 1501-1507
7 p.
|
artikel
|
| 20 |
Neuroblastoma
|
Castleberry, R.P.
|
|
1997
|
33 |
9 |
p. 1430-1437
8 p.
|
artikel
|
| 21 |
Neurological monitoring of neurotoxicity induced by paclitaxel/cisplatin chemotherapy
|
Berger, T.
|
|
1997
|
33 |
9 |
p. 1393-1399
7 p.
|
artikel
|
| 22 |
Oxaliplatin/cisplatin (L-OHP/CDDP) combination in heavily pretreated ovarian cancer
|
Soulié, P.
|
|
1997
|
33 |
9 |
p. 1400-1406
7 p.
|
artikel
|
| 23 |
Paclitaxel changes sympathetic control of blood pressure
|
Ekholm, E.
|
|
1997
|
33 |
9 |
p. 1419-1424
6 p.
|
artikel
|
| 24 |
Pharmacokinetics of amifostine and its metabolites in patients
|
Korst, A.E.C.
|
|
1997
|
33 |
9 |
p. 1425-1429
5 p.
|
artikel
|
| 25 |
Phase II study of weekly 4′-epidoxorubicin in patients with metastatic adenocarcinoma of the cervix: an EORTC gynaecological cancer cooperative group study
|
van der Burg, M.E.L.
|
|
1997
|
33 |
9 |
p. 1513-1515
3 p.
|
artikel
|
| 26 |
Phase II trials in the EORTC
|
The protocol review committee,
|
|
1997
|
33 |
9 |
p. 1361-1363
3 p.
|
artikel
|
| 27 |
Predictive value of serum medroxyprogesterone acetate concentration for response in advanced or recurrent breast cancer
|
Nishimura, R.
|
|
1997
|
33 |
9 |
p. 1407-1412
6 p.
|
artikel
|
| 28 |
Prognostic factors for advanced seminoma—a solid basis for clinical trials
|
Schmoll, H.-J.
|
|
1997
|
33 |
9 |
p. 1347-1350
4 p.
|
artikel
|
| 29 |
Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapy
|
Fosså, S.D.
|
|
1997
|
33 |
9 |
p. 1380-1387
8 p.
|
artikel
|
| 30 |
Quantification of additional short arms of chromosome 12 in germ cell tumours using the polymerase chain reaction
|
Malek, N.P.
|
|
1997
|
33 |
9 |
p. 1488-1494
7 p.
|
artikel
|
| 31 |
Remarkable age-dependent sex differences in the incidence of adenocarcinoma of the gastric cardia and oesophagus in The Netherlands
|
Scheuten, L.J.
|
|
1997
|
33 |
9 |
p. 1519-
1 p.
|
artikel
|
| 32 |
Should high-dose chemotherapy be used in the treatment of soft tissue sarcoma?
|
Crowther, D.
|
|
1997
|
33 |
9 |
p. 1359-1360
2 p.
|
artikel
|
| 33 |
Should high-dose chemotherapy be used in the treatment of soft tissue sarcoma?
|
Verweij, J.
|
|
1997
|
33 |
9 |
p. 1354-1359
6 p.
|
artikel
|
| 34 |
Should high-dose chemotherapy be used in the treatment of soft tissue sarcoma?
|
Reichardt, P.
|
|
1997
|
33 |
9 |
p. 1351-1354
4 p.
|
artikel
|
| 35 |
The United Kingdom children's cancer study group—the first 20 years of growth and development
|
Mott, M.G.
|
|
1997
|
33 |
9 |
p. 1448-1452
5 p.
|
artikel
|
| 36 |
The U.S. pediatric cancer clinical trials programmes: International implications and the way forward
|
Bleyer, W.A.
|
|
1997
|
33 |
9 |
p. 1439-1447
9 p.
|
artikel
|
Tijdschrift beschrijving